UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study

JNCI : Journal of the National Cancer Institute, 2012-09, Vol.104 (17), p.1293-1305

2012

Volltextzugriff (PDF)

Ambulatory-treated Clostridium difficile infection: a comparison of community-acquired vs. nosocomial infection

Epidemiology and infection, 2015-04, Vol.143 (6), p.1225-1235

2015

Volltextzugriff (PDF)

Twelve‐month outcomes and predictors of very stable INR control in prevalent warfarin users

Journal of thrombosis and haemostasis, 2010-04, Vol.8 (4), p.744-749

2010

Volltextzugriff (PDF)

Incidence and predictors of bleeding or thrombosis after polypectomy in patients receiving and not receiving anticoagulation therapy

Journal of thrombosis and haemostasis, 2009-12, Vol.7 (12), p.1982-1989

2009

Volltextzugriff (PDF)

An evaluation of the potential drug interaction between warfarin and levothyroxine

Journal of thrombosis and haemostasis, 2014-08, Vol.12 (8), p.1313-1319

2014

Volltextzugriff (PDF)

PCV55 COST-MINIMIZATION ANALYSIS OF THROMBOPROPHYLAXIS FOLLOWING ELECTIVE TOTAL HIP ARTHROPLASTY

Value in health, 2011, Vol.14 (3), p.A42-A42

2011

Volltextzugriff (PDF)

Thromboembolic Consequences of Subtherapeutic Anticoagulation in Patients Stabilized on Warfarin Therapy: The Low INR Study

Journal of vascular surgery, 2009, Vol.49 (4), p.1085-1085

2009

Volltextzugriff (PDF)

The Use of 2 Health-Related Quality-of-Life Measures in a Sample of Persons Infected with Human Immunodeficiency Virus

Clinical infectious diseases, 2001-02, Vol.32 (3), p.e47-e52

2001

Volltextzugriff (PDF)

Patterns of use of sildenafil among commercially insured adults in the United States: 1998-2002

International journal of impotence research, 2004-08, Vol.16 (4), p.313-318

2004

Volltextzugriff (PDF)

P5590Temporal trends in first-line anticoagulation therapy for cancer-associated venous thromboembolism

European heart journal, 2019-10, Vol.40 (Supplement_1)

2019

Volltextzugriff (PDF)

PBI2 Real-World Evaluation of Biosimilar Bevacizumab-awwb versus Reference Bevacizumab in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer in a U.S. Integrated Healthcare Delivery System: 6-Month Interim Analysis

Value in health, 2021-06, Vol.24, p.S14-S14

2021

Volltextzugriff (PDF)

The clinical consequence of subtherapeutic anticoagulation: the low INR study (LINeRS)

Journal of thrombosis and thrombolysis, 2008-02, Vol.25 (1), p.127-128

2008

Volltextzugriff (PDF)

Assessment of the rates and characteristics of the short-term supply of medication (Tider) from an integrated healthcare delivery system in the United States

Pharmacy practice, 2017-04, Vol.15 (2), p.940-940

2017

Volltextzugriff (PDF)

Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2023-06, Vol.329 (22), p.1924

2023

Volltextzugriff (PDF)

Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by 24(S),25-oxidolanosterol

The Journal of biological chemistry, 1992-06, Vol.267 (18), p.12647-12654

1992

Volltextzugriff (PDF)

Outcomes and predictors of very stable INR control during chronic anticoagulation therapy

Blood, 2009-07, Vol.114 (5), p.952-956

2009

Volltextzugriff (PDF)

Trends in the Use of Antidepressants in a National Sample of Commercially Insured Pediatric Patients, 1998 to 2002

Psychiatric services (Washington, D.C.), 2004-04, Vol.55 (4), p.387-391

2004

Volltextzugriff (PDF)

Trends in high intensity statin use among secondary prevention patients 76 years and older

Pharmacy practice, 2019-04, Vol.17 (2), p.1402-1402

2019

Volltextzugriff (PDF)

Warfarin and Antiplatelet Combination Use Among Commercially Insured Patients Enrolled in an Anticoagulation Management Service

Chest, 2007-05, Vol.131 (5), p.1500-1507

2007

Volltextzugriff (PDF)

Feasibility of clinical pharmacist-led CYP2C19 genotyping for patients receiving non-emergent cardiac catheterization in an integrated health system

Pharmacy practice, 2017-04, Vol.15 (2), p.946-946

2017

Volltextzugriff (PDF)

Clinical and financial outcomes associated with a proton pump inhibitor prior-authorization program in a Medicaid population

The American journal of managed care, 2005-01, Vol.11 (1), p.29-36

2005

Volltextzugriff (PDF)

A2-5: Factors Independently Associated with Receiving First-Line Bevacizumab for Advanced Non-Small Cell Lung Cancer

Clinical medicine & research, 2013-09, Vol.11 (3), p.124-124

2013

Volltextzugriff (PDF)

CC4-02: Comparative Effectiveness of Chemotherapy Regimens for Advanced Lung Cancer

Clinical medicine & research, 2012-08, Vol.10 (3), p.158-158

2012

Volltextzugriff (PDF)

The discriminative ability of the 12-Item short form health survey (SF-12) in a sample of persons infected with HIV

Clinical therapeutics, 2000-09, Vol.22 (9), p.1112-1120

2000

Volltextzugriff (PDF)

CB2-04: Use of the Oncology Beacon Module and VDW Data to Identify Variations in Treatment for Advanced Colorectal Cancer

Clinical medicine & research, 2012-08, Vol.10 (3), p.152-152

2012

Volltextzugriff (PDF)

1 – 25 von 350

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(311)
Mit Volltextzugriff
(282)

Publikationsform

Sprache

Englisch
(341)
Französisch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study

Ambulatory-treated Clostridium difficile infection: a comparison of community-acquired vs. nosocomial infection

Twelve‐month outcomes and predictors of very stable INR control in prevalent warfarin users

Incidence and predictors of bleeding or thrombosis after polypectomy in patients receiving and not receiving anticoagulation therapy

An evaluation of the potential drug interaction between warfarin and levothyroxine

PCV55 COST-MINIMIZATION ANALYSIS OF THROMBOPROPHYLAXIS FOLLOWING ELECTIVE TOTAL HIP ARTHROPLASTY

Thromboembolic Consequences of Subtherapeutic Anticoagulation in Patients Stabilized on Warfarin Therapy: The Low INR Study

The Use of 2 Health-Related Quality-of-Life Measures in a Sample of Persons Infected with Human Immunodeficiency Virus

Patterns of use of sildenafil among commercially insured adults in the United States: 1998-2002

P5590Temporal trends in first-line anticoagulation therapy for cancer-associated venous thromboembolism

PBI2 Real-World Evaluation of Biosimilar Bevacizumab-awwb versus Reference Bevacizumab in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer in a U.S. Integrated Healthcare Delivery System: 6-Month Interim Analysis

The clinical consequence of subtherapeutic anticoagulation: the low INR study (LINeRS)

Assessment of the rates and characteristics of the short-term supply of medication (Tider) from an integrated healthcare delivery system in the United States

Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer: A Randomized Clinical Trial

Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by 24(S),25-oxidolanosterol

Outcomes and predictors of very stable INR control during chronic anticoagulation therapy

Trends in the Use of Antidepressants in a National Sample of Commercially Insured Pediatric Patients, 1998 to 2002

Trends in high intensity statin use among secondary prevention patients 76 years and older

Warfarin and Antiplatelet Combination Use Among Commercially Insured Patients Enrolled in an Anticoagulation Management Service

Feasibility of clinical pharmacist-led CYP2C19 genotyping for patients receiving non-emergent cardiac catheterization in an integrated health system

Clinical and financial outcomes associated with a proton pump inhibitor prior-authorization program in a Medicaid population

A2-5: Factors Independently Associated with Receiving First-Line Bevacizumab for Advanced Non-Small Cell Lung Cancer

CC4-02: Comparative Effectiveness of Chemotherapy Regimens for Advanced Lung Cancer

The discriminative ability of the 12-Item short form health survey (SF-12) in a sample of persons infected with HIV

CB2-04: Use of the Oncology Beacon Module and VDW Data to Identify Variations in Treatment for Advanced Colorectal Cancer

Suchergebnisse filtern